FDA Decries Erectile Dysfunction Drug Promo In New Warning

By Kevin Stawicki ( August 26, 2019, 8:00 PM EDT) -- Metuchen Pharmaceuticals LLC improperly promoted its erectile dysfunction drug by erroneously claiming it can help reduce the risk of heart failure and neglecting to mention that it can cause irreversible erectile tissue damage, the U.S. Food and Drug Administration said in its first warning letter of the year....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!